Cardiovascular Disease and Tobacco: Where do we go from here - PowerPoint PPT Presentation

1 / 31
About This Presentation
Title:

Cardiovascular Disease and Tobacco: Where do we go from here

Description:

A very limited number of health-related behaviors practiced by ... million teenagers age 12 to 17 are smokers, and 3,400 Teenagers begin smoking every day. ... – PowerPoint PPT presentation

Number of Views:117
Avg rating:3.0/5.0
Slides: 32
Provided by: cvhpins
Category:

less

Transcript and Presenter's Notes

Title: Cardiovascular Disease and Tobacco: Where do we go from here


1
Cardiovascular Disease and Tobacco Where do we
go from here?
  • Scott McIntosh, PhD
  • Smoking Research Program, University of Rochester
  • Department of Community and Preventive Medicine
  • e-mail smcintosh_at_yahoo.com

2
Outline of Presentation
  • CVD and Smoking
  • Epidemiology of Smoking
  • Treatment (Cessation) Options

3
CVD Risk Behaviors
  • A very limited number of health-related
    behaviors practiced by people every day
    contribute markedly to CVD.
  • These are Lack of Physical Activity, Poor
    Nutrition, and Smoking.

4
CVD Risk Behavior SMOKING
  • Cigarette smoking is a major cause of heart
    disease among both men and women.
  • Smokers have twice the risk for heart attack as
    non-smokers.
  • Nearly 1/5 of all deaths from CVD, or about
    180,000 each year, are attributable to smoking.

5
CIGARETTE SMOKING-RELATED ILLNESS
6
Cardiovascular Disease DeathsAttributable to
Cigarette Smoking
7
CVD Risk Behavior SMOKING
  • Smoking is the most important of the known
    modifiable risk factors for coronary heart
    disease in the United States. (Surgeon General)
  • Smoking interacts with other risk factors to
    greatly increase the risk for coronary heart
    disease.
  • Smoke from other people (ETS) causes up to
    40,000 people to die each year from heart and
    blood vessel disease.

8
Cigarette Smoking Interactions with other risk
factors
  • The ratio of high-density lipoprotein cholesterol
    to low-density lipoprotein cholesterol is lower
    in cigarette smokers than in nonsmokers.
  • Smoking combined with a family history of heart
    disease greatly increases the risk.

9
How Smoking Directly affects Cardiovascular
System
  • Added strain on heart causes vessels to clamp
    down or constrict.
  • If vessels have already been narrowed or damaged
    by heart disease, smoking makes the problem
    worse.
  • Smoking causes temporary changes in the heart
    beats faster, BP raises, and blood flow reduces.
  • Smoking increases the level of carbon monoxide in
    the blood, which robs the heart and other tissues
    of oxygen.

10
Smoking Epidemiology
  • 25.2 million men (26.7) and 23.2 million women
    (22.8) are smokers, putting them at increased
    risk of heart attack.
  • 4.1 million teenagers age 12 to 17 are smokers,
    and 3,400 Teenagers begin smoking every day.
  • If trends continue, approximately 5 million
    persons under 18 years old will die eventually
    from a smoking-attributable disease.

11
High School Smokers
12
Prevalence () of Current Cigarette Smoking
amongHigh School Students, by Race and Sex,
1991-1997 Smoked cigarettes on at least one of
the 30 days preceding the survey. Source Youth
Risk Behavior Surveys, 1991-1997
13
Education
14
Per Capita Consumption
15
The United States population has Asymptoted
Out just around 25
16
Short Long-Term Benefits of Quitting
17
Where do we go from here?
  • Strides in Research and Practice
  • Prevention
  • School-based programs
  • Treatment
  • New focus on Cessation Intervention for Teens
  • Theory Development
  • Transtheoretical Model of Behavioral Change
    Stages of Change (Prochaska,
    DiClemente, et al.)
  • Practical Developments
  • AHCPR Guidelines, e.g., for physician
    intervention

18
STAGES OF CHANGE
  • Transtheoretical Model of Behavioral Change as
    applied to a variety of risk behaviors, not just
    Smoking Cessation
  • The stages (using Smoking Cessation as example)
    are
  • Precontemplation (Not Considering Quitting)
  • Contemplation (Considering Quitting in Near
    Future)
  • Preparation (Getting Ready to Quit Soon)
  • Action (Taking Necessary Steps to Quit)
  • Maintenance (Remaining Abstinent from Cigarettes)
  • Relapse/Recycling (Return to an earlier Stage of
    Change)

19
Practical DevelopmentsThe AHCPR Guidelines
  • AHCPR Guidelines (1996, 2000) Include Reports of
    effectiveness of all recognized, research-based
    Smoking Cessation Strategies, including
  • Social Support (e.g., Family/Friends, Classes,
    Phone Support)
  • New Behaviors (e.g., Manuals, Beh Mod,
    Relaxation)
  • Pharmacology (e.g., NRT, Zyban)
  • Minimal Intervention Strategies for Practitioners
  • Three Minute Intervention
  • The 4 As Ask, Advise, Assist, Arrange

20
The AHCPR Guidelines The 4 AsASK, ADVISE,
ASSIST, ARRANGE
  • ASK Systematically Identify all Tobacco Users at
    Every Visit
  • Office-wide system, document every patient,
    every visit.
  • ADVISE Strongly Urge all Smokers to Quit
  • Ask every smoker if he or she is willing to make
    a quit attempt
  • If not willing to make a quit attempt at this
    time, provide motivational intervention
    (relevance, risks, rewards, repetition).
  • Use clear, strong, and personalized manner.

21
ASK, ADVISE, ASSIST, ARRANGE
  • ASSIST Aid the Patient in Quitting
  • Help patient with a quit plan.
  • Provide supplementary materials.
  • ARRANGE Schedule Follow-Up Contact
  • In person or via telephone.
  • Should occur soon after quit date, preferably in
    first week.
  • Congratulate success or review circumstances of
    relapse.

22
Practical DevelopmentsThe AHCPR Guidelines
  • AHCPR Guidelines
  • Vital Signs to include SMOKING
  • Self-Help Interventions
  • New Pharmacological Interventions
  • Patch and Gum Now Over-The-Counter
  • Spray and Inhaler Now Prescription
  • Lollipops, Lozenges, Hard Candy, Etc. Being
    Developed
  • Zyban (a.k.a., Wellbutrin )

23
Tobacco Use as a Vital Sign
  • Vital Signs Strategy
  • Include SMOKING (Tobacco Use) as a vital sign in
    addition to BP, Pulse, Weight, Body Temperature,
    and Respiratory Rate.
  • This example is a sticker for a patients medical
    chart
  • A new one should be added to the chart every visit

24
Self-Help Interventions
  • Clinics are very effective, but only 10 of
    smokers will use them
  • Self-Help Methods can include
  • Hotline / Proactive Calls
  • Manual (Tailored may help)
  • Pamphlets / Proact. Mailings
  • Medications (NRT, Zyban)
  • Behavioral Programs
  • Best (most effective) may be a combination of
    these

25
Nicotine Gum and Nicotine Patch
  • Gum 12mo abstinence 18
  • Patch 12mo abstinence 25

26
Medication Zyban (a.k.a., Wellbutrin )
  • Only Non-nicotine medication shown to be
    effective (19 abst. at 6 mos)
  • Works on both craving and withdrawal pathways
    in the brain
  • Can be used with NRT
  • 8 to 12 weeks, but currently trials are assessing
    longer treatment
  • Begin ONE WEEK before Cold Turkey Quit Date
  • Many physicians prescribe Wellbutrin instead
    Same Drug, should be used same way, with
    behavioral component
  • 36 Abstinence at 1 month, 19 Abstinence at 6
    months

27
New Funding PossibilitiesThe Lawsuits
  • Class Action Lawsuits in landmark decisions are
    occurring at the State and Federal levels
  • 9/22/99 the U.S. Department of Justice filed a
    lawsuit seeks monetary recovery for the more than
    20 billion a year that the Federal Government
    spends on treating smoking-related diseases under
    Federal health programs
  • However, these funds are often earmarked for
    non-Tobacco Control efforts
  • Funding should go directly to Tobacco Control
    Efforts Prevention, Treatment, and Research

28
Program DevelopmentPoints to Keep in Mind
  • Classes / Clinics should be about 30 minutes
    long, with between 4 and 7 sessions
  • Problem-solving /skills training
  • danger situations
  • coping skills
  • information on smoking and quitting
  • The 4 Rs
  • Relevance
  • Risks
  • Rewards
  • Repetition
  • Provide Relapse Prevention Intervention
  • Include Pharmacotherapy

29
References
  • DiClemente, CC, Prochaska, JO, et al. (1991) The
    Process of Smoking Cessation An Analysis of
    Precontemplation, Contemplation, and Preparation
    Stages of Change. Journal of Consulting and
    Clinical Psychology, 59(2)295-304.
  • Fiore MC, Wetter DW, Bailey WC, et al. (1996)
    Smoking Cessation Clinical Practice Guideline.
    Rockville, MD Agency for Health Care Policy and
    Research, Public Health Service, US Department of
    Health and Human Services.
  • Gilpin EA, Choi WS, Berry C, Pierce JP (1999) How
    many adolescents start smoking each day in the
    United States? Journal of Adolescent Health, 25
    248-255.

30
(No Transcript)
31
CVD and Tobacco
  • THANK YOU
  • Scott McIntosh, PhD
  • Smoking Research Program, University of Rochester
  • e-mail smcintosh_at_yahoo.com
Write a Comment
User Comments (0)
About PowerShow.com